ArticleJournal of magnetism and magnetic materials2025
Characterization and Evaluation of Commercial Tracers for X-Space Magnetic Particle Imaging.
Article in Journal of magnetism and magnetic materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Towards reliable tracking of natural killer cells using commercial iron oxide nanoparticles and magnetic particle imaging.Biomaterials science · 2026Article
- Ultrasensitive detection of lung inflammation in male mice using immuno-magnetic particle imaging.Nature communications · 2026Article
- Signal Intensity versus Spatial Resolution: Divergent MPI Performance of SPIONs in Mesenchymal Stromal Cell Labelling.International journal of nanomedicine · 2026Article
- Superferromagnetic Disk Particles for Magnetic Particle Imaging.Small methods · 2025Article
- Article
- Synthesis and Characterization of a Nanoscale Hyaluronic Acid-Specific Probe for Magnetic Particle Imaging and Magnetic Resonance Imaging.Nanomaterials (Basel, Switzerland) · 2025Article
- Flame-Made Doped Iron Oxide Nanoparticles as Tracers for Magnetic Particle Imaging.Chemistry of materials : a publication of the American Chemical Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Commercial magnetic particle imaging (MPI) tracers are utilized for many applications including as reference materials for comparing tracer performance, but comparative measurements of many tracers on a single imaging platform are uncommon. This study uses relaxometry and 2D imaging in a pre-clinical MOMENTUM scanner to characterize and evaluate the performance of six common commercial tracers for MPI: Synomag-D Plain, Synomag-D NH2, Synomag-D PEG, Perimag, Vivotrax, and Vivotrax Plus. Repeated measurements of samples showed considerable variability while inter-sample differences were generally negligible. Sensitivity between the two modes is strongly correlated while resolution of the two modes was only moderately correlated. Further, relaxometric measurements tend to predict better resolution than is achieved in 2D imaging. All evaluated tracers have resolutions within 1 mm of each other on the MOMENTUM imager. These results illustrate that relaxometer measurements can be used to broadly predict MPI performance but do not accurately recreate the physical processes or differences in hardware and software of MPI. This study provides MPI measurements of tracers that may be useful to researchers while highlighting the challenges of making comparisons between tracers due to variation within samples and across different measurement techniques and instruments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.